...
首页> 外文期刊>Oncogene >Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
【24h】

Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors

机译:人乳头瘤病毒16型E6和E7型癌蛋白在原发包皮角质形成细胞中的表达足以改变血管生成因子的表达

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Human papillomavirus (HPV) 16 is involved in causing cervical cancer. The E6 and E7 proteins of HPV 16 immortalize human keratinocytes and this is due, at least in part, to inactivation of the tumor suppressor proteins p53 and pRB. These tumor suppressor proteins also regulate the expression of pro- and antiangiogenic factors by cells. For this reason, experiments were conducted to determine whether the expression of E6 and E7 in primary keratinocytes alters the phenotype of these cells such that they express diminished levels of antiangiogenic factors and/or increased levels of proangiogenic factors. To avoid variances in experimental observations, pools of human foreskin keratinocytes from multiple sources were infected with recombinant retrovirus expressing HPV 16 E6 and E7 or control retrovirus. Gene array analysis, RT–PCR, ELISAs and Western blotting showed that in cells expressing HPV 16 E6 and E7, expression levels of two potent angiogenesis inhibitors, thrombospondin-1 and maspin, were lower compared to controls. Additionally, major angiogenesis inducers, interleukin-8 and vascular endothelial growth factor (VEGF), were increased relative to controls. VEGF can be produced as multiple splice variants, all of which are required for the formation of patent blood vessels. The expression of HPV 16 E6 and E7 in keratinocytes augmented expression of VEGF 121, 145, 165 and 189. These observations show that HPV 16 E6 and E7 alter the phenotype of primary keratinocytes, diminishing expression of inhibitors and increasing expression of inducers of angiogenesis. This altered phenotype may permit keratinocytes infected by HPV 16 to play a role in the progression of cancer by permitting tumors to acquire a blood supply permissive of growth and spread.
机译:人乳头瘤病毒(HPV)16参与导致子宫颈癌。 HPV 16的E6和E7蛋白使人类角质形成细胞永生,这至少部分是由于抑癌蛋白p53和pRB的失活所致。这些肿瘤抑制蛋白还通过细胞调节促血管生成因子和抗血管生成因子的表达。因此,进行实验以确定原代角质形成细胞中E6和E7的表达是否改变了这些细胞的表型,从而使它们表达的抗血管生成因子水平降低和/或表达的血管生成因子水平升高。为避免实验观察结果出现差异,用表达HPV 16 E6和E7的重组逆转录病毒或对照逆转录病毒感染多种来源的人包皮角质形成细胞。基因阵列分析,RT-PCR,ELISA和Western blotting显示,在表达HPV 16 E6和E7的细胞中,两种有效的血管生成抑制剂thrombospondin-1和maspin的表达水平低于对照组。另外,相对于对照,主要的血管生成诱导剂,白介素8和血管内皮生长因子(VEGF)增加。 VEGF可以作为多个剪接变体产生,所有这些都需要形成专利血管。 HPV 16 E6和E7在角质形成细胞中的表达增强了VEGF 121、145、165和189的表达。这些观察结果表明,HPV 16 E6和E7改变了原代角质形成细胞的表型,减少了抑制剂的表达并增加了血管生成诱导剂的表达。这种改变的表型可以通过允许肿瘤获得允许生长和扩散的血液供应,从而使被HPV 16感染的角质形成细胞在癌症的发展中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号